Yuva Biosciences Inc, an anti-aging company developing cosmeceuticals as well as pharmaceuticals targeted at aging-associated hair loss, wrinkled skin, and reduced energy, announced yesterday that it has added Aubrey de Grey, PhD and Frank L Jaksch, Jr to its Advisory Board.

Aubrey de Grey is the chief science officer of SENS Research Foundation. He is also editor-in-chief of Rejuvenation Research. He is a speaker who gives 40-50 invited talks per year at scientific conferences, universities and companies, in areas ranging from pharma to life insurance, and to the public. He dedicates 30% of his time to AgeX Therapeutics (ticker symbol: AGE), where he is the vice president, New Technology Discovery.

Frank L Jaksch, Jr, the co-founder of ChromaDex, is biochemist with a track record for successfully licensing and bringing breakthrough science to the supplements industry. As the first to honour the commercial potential of nicotinamide riboside, he received the exclusive license to bring NR to market through ChromaDex (NASDAQ: CDXC) where he remains the executive chairman. He continues to drive the company's scientific research strategy with a focus on translating the science into commercial success.